Concepedia

Isabelle Scheer-Senyarich

IS

Statistics

Publications

6

Citations

805

H-Index

6

Active since

2011

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Université Paris Cité

Hôpital Bichat-Claude-Bernard

Délégation Paris 7

Centre Hospitalier Universitaire de Bordeaux

Isabelle Scheer-Senyarich is an author at Assistance Publique – Hôpitaux de Paris specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

2011–2020

6

Publications

6

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

E. Maubec, Peter Petrow, Isabelle Scheer-Senyarich et al. · Journal of Clinical Oncology · 2011 · 467 citations · Full text

, , +17

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 174 citations

, , +16

Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages

Giulia Fregni, Meriem Messaoudene, Emmanuelle Fourmentraux-Neves et al. · PLoS ONE · 2013 · 65 citations · Full text

, , +16

Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin

E. Maubec, Cédric Laouenan, Lydia Deschamps et al. · Journal of Investigative Dermatology · 2015 · 56 citations

, , +5

Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2018 · 24 citations

, , +17

1–5 of 6